292 related articles for article (PubMed ID: 25242307)
1. Social learning and amygdala disruptions in Nf1 mice are rescued by blocking p21-activated kinase.
Molosh AI; Johnson PL; Spence JP; Arendt D; Federici LM; Bernabe C; Janasik SP; Segu ZM; Khanna R; Goswami C; Zhu W; Park SJ; Li L; Mechref YS; Clapp DW; Shekhar A
Nat Neurosci; 2014 Nov; 17(11):1583-90. PubMed ID: 25242307
[TBL] [Abstract][Full Text] [Related]
2. Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1.
Costa RM; Federov NB; Kogan JH; Murphy GG; Stern J; Ohno M; Kucherlapati R; Jacks T; Silva AJ
Nature; 2002 Jan; 415(6871):526-30. PubMed ID: 11793011
[TBL] [Abstract][Full Text] [Related]
3. Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells.
McDaniel AS; Allen JD; Park SJ; Jaffer ZM; Michels EG; Burgin SJ; Chen S; Bessler WK; Hofmann C; Ingram DA; Chernoff J; Clapp DW
Blood; 2008 Dec; 112(12):4646-54. PubMed ID: 18768391
[TBL] [Abstract][Full Text] [Related]
4. Neurofibromin regulation of ERK signaling modulates GABA release and learning.
Cui Y; Costa RM; Murphy GG; Elgersma Y; Zhu Y; Gutmann DH; Parada LF; Mody I; Silva AJ
Cell; 2008 Oct; 135(3):549-60. PubMed ID: 18984165
[TBL] [Abstract][Full Text] [Related]
5. Neurobehavioral sex-related differences in Nf1
Santos S; Martins B; Sereno J; Martins J; Castelo-Branco M; Gonçalves J
Biol Sex Differ; 2023 Apr; 14(1):24. PubMed ID: 37101298
[TBL] [Abstract][Full Text] [Related]
6. Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice.
Sharma R; Wu X; Rhodes SD; Chen S; He Y; Yuan J; Li J; Yang X; Li X; Jiang L; Kim ET; Stevenson DA; Viskochil D; Xu M; Yang FC
Hum Mol Genet; 2013 Dec; 22(23):4818-28. PubMed ID: 23863460
[TBL] [Abstract][Full Text] [Related]
7. HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.
Omrani A; van der Vaart T; Mientjes E; van Woerden GM; Hojjati MR; Li KW; Gutmann DH; Levelt CN; Smit AB; Silva AJ; Kushner SA; Elgersma Y
Mol Psychiatry; 2015 Nov; 20(11):1311-21. PubMed ID: 25917366
[TBL] [Abstract][Full Text] [Related]
8. Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro.
Ingram DA; Hiatt K; King AJ; Fisher L; Shivakumar R; Derstine C; Wenning MJ; Diaz B; Travers JB; Hood A; Marshall M; Williams DA; Clapp DW
J Exp Med; 2001 Jul; 194(1):57-69. PubMed ID: 11435472
[TBL] [Abstract][Full Text] [Related]
9. Motor deficits and neurofibromatosis type 1 (NF1)-associated MRI impairments in a mouse model of NF1.
Robinson A; Kloog Y; Stein R; Assaf Y
NMR Biomed; 2010 Dec; 23(10):1173-80. PubMed ID: 20586111
[TBL] [Abstract][Full Text] [Related]
10. Oligodendrocyte Nf1 Controls Aberrant Notch Activation and Regulates Myelin Structure and Behavior.
López-Juárez A; Titus HE; Silbak SH; Pressler JW; Rizvi TA; Bogard M; Bennett MR; Ciraolo G; Williams MT; Vorhees CV; Ratner N
Cell Rep; 2017 Apr; 19(3):545-557. PubMed ID: 28423318
[TBL] [Abstract][Full Text] [Related]
11. Perfusion single photon emission computed tomography in a mouse model of neurofibromatosis type 1: towards a biomarker of neurologic deficits.
Apostolova I; Niedzielska D; Derlin T; Koziolek EJ; Amthauer H; Salmen B; Pahnke J; Brenner W; Mautner VF; Buchert R
J Cereb Blood Flow Metab; 2015 Aug; 35(8):1304-12. PubMed ID: 25785829
[TBL] [Abstract][Full Text] [Related]
12. Restored plasticity in a mouse model of neurofibromatosis type 1 via inhibition of hyperactive ERK and CREB.
Guilding C; McNair K; Stone TW; Morris BJ
Eur J Neurosci; 2007 Jan; 25(1):99-105. PubMed ID: 17241271
[TBL] [Abstract][Full Text] [Related]
13. Enriched expression of NF1 in inhibitory neurons in both mouse and human brain.
Ryu HH; Kang M; Park J; Park SH; Lee YS
Mol Brain; 2019 Jun; 12(1):60. PubMed ID: 31234911
[TBL] [Abstract][Full Text] [Related]
14. Light exposure before learning improves memory consolidation at night.
Shan LL; Guo H; Song NN; Jia ZP; Hu XT; Huang JF; Ding YQ; Richter-Levin G; Zhou QX; Xu L
Sci Rep; 2015 Oct; 5():15578. PubMed ID: 26493375
[TBL] [Abstract][Full Text] [Related]
15. Motivational disturbances and effects of L-dopa administration in neurofibromatosis-1 model mice.
Wozniak DF; Diggs-Andrews KA; Conyers S; Yuede CM; Dearborn JT; Brown JA; Tokuda K; Izumi Y; Zorumski CF; Gutmann DH
PLoS One; 2013; 8(6):e66024. PubMed ID: 23762458
[TBL] [Abstract][Full Text] [Related]
16. A porcine model of neurofibromatosis type 1 that mimics the human disease.
White KA; Swier VJ; Cain JT; Kohlmeyer JL; Meyerholz DK; Tanas MR; Uthoff J; Hammond E; Li H; Rohret FA; Goeken A; Chan CH; Leidinger MR; Umesalma S; Wallace MR; Dodd RD; Panzer K; Tang AH; Darbro BW; Moutal A; Cai S; Li W; Bellampalli SS; Khanna R; Rogers CS; Sieren JC; Quelle DE; Weimer JM
JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925695
[TBL] [Abstract][Full Text] [Related]
17. Legius syndrome, an Update. Molecular pathology of mutations in SPRED1.
Brems H; Legius E
Keio J Med; 2013; 62(4):107-12. PubMed ID: 24334617
[TBL] [Abstract][Full Text] [Related]
18. NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
Xu J; Ismat FA; Wang T; Yang J; Epstein JA
Circulation; 2007 Nov; 116(19):2148-56. PubMed ID: 17967772
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors.
Dasgupta B; Yi Y; Chen DY; Weber JD; Gutmann DH
Cancer Res; 2005 Apr; 65(7):2755-60. PubMed ID: 15805275
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent manner.
Brown JA; Diggs-Andrews KA; Gianino SM; Gutmann DH
Mol Cell Neurosci; 2012 Jan; 49(1):13-22. PubMed ID: 21903164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
